BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 13871986)

  • 1. [Lanatoside C in hospital therapeutics].
    BOUVRAIN Y; BOURTHOUMIEUX A; BRUNET JP
    Prog Med (Paris); 1962 May; 90():302-6. PubMed ID: 13871986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of the administration of lanatoside C in cardiocirculatory decompensation].
    MARTELLI A
    Gazz Med Ital; 1961 Jul; 120():250-5. PubMed ID: 13767271
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution to cardiotonic therapy by oral route with deacetyl-lanatoside C and diethlamino-phenyl-ethylbarbiturate].
    FANCINI P
    Gazz Med Ital; 1961 Dec; 120():479-82. PubMed ID: 13891504
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of lanatoside C (cedilanid) in cardiac arrythmias and congestive failure.
    WEISBERG A
    N Y State J Med; 1954 Jun; 54(11):1652-8. PubMed ID: 13165977
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lanatoside C therapy of cardiac insufficiency].
    SOTTI L; RIONDATO O
    G Clin Med; 1952 Jun; 33(6):617-34. PubMed ID: 12989547
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peroral continous therapy of the chronic muscular cardiac insufficiency with lanatoside C].
    DOROW H; BIALKOWSKI J
    Arztl Wochensch; 1953 Feb; 8(7):162-5. PubMed ID: 13057761
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of lanatoside C on circulatory insufficiency].
    PNIAKOWSKA Z
    Pol Tyg Lek (Wars); 1952 Feb; 7(7-8):169-76. PubMed ID: 14929733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of cardiac insufficiency with simultaneously administered lanatoside C & scillaren].
    GONNELLA CG
    Dia Med; 1957 Dec; 29(93):3535-6. PubMed ID: 13501055
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lanatoside C: indications and results].
    DAVID P; EDDIE ES
    Union Med Can; 1956 Mar; 85(3):271-82. PubMed ID: 13325047
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lanatoside A in differential therapy of cardiac insufficiency].
    HOFER E
    Munch Med Wochenschr; 1958 May; 100(22):875-7. PubMed ID: 13565978
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative study on the use of the purified digitalis glycosides, digoxin, digitoxin, and lanatoside C, for the management of ambulatory patients with congestive heart failure.
    BATTERMAN RC; DE GRAFF AC
    Am Heart J; 1947 Nov; 34(5):663-73. PubMed ID: 20268229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological and clinical considerations on the association ATP-cardiac glycosides (lanatoside C, strophanthin) in the treatment of arteriosclerotic heart disease].
    DE CAROLIS GD
    Atti Soc Ital Cardiol; 1959; 21(2)():Comunicazioni 115-7. PubMed ID: 13814704
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of paroxysmal supraventricular tachycardia with lanatoside C.
    BARROW JG
    Ann Intern Med; 1950 Jan; 32(1):116-9. PubMed ID: 15404130
    [No Abstract]   [Full Text] [Related]  

  • 14. [Saturation therapy with lanatoside C].
    JOHN S
    Munch Med Wochenschr; 1961 Jun; 103():1228-33. PubMed ID: 13790214
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of childhood cardiac insufficiency with lanatoside C].
    GRANATA G; PARENZAN L
    Minerva Pediatr; 1955 Oct; 7(42):1292-300. PubMed ID: 13279854
    [No Abstract]   [Full Text] [Related]  

  • 16. The intravenous administration of lanatoside C to patients taking maintenance doses of folia digitalis up to the date of hospitalization with recurrent congestive heart failure.
    RAY T; LaDUE JS
    Proc Am Fed Clin Res; 1945; 2():20. PubMed ID: 20275581
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical observations on the effects of lanatoside A on tachycardiac fibrillation arrhythmia; clinical aspects of the new pure glycoside].
    VOIGT G
    Munch Med Wochenschr; 1955 Oct; 97(42):1394-7. PubMed ID: 13288423
    [No Abstract]   [Full Text] [Related]  

  • 18. [DIFFERENTIATED USE OF CARDIAC GLYCOSIDES].
    BAYER O
    Hippokrates; 1964 Feb; 35():140-3. PubMed ID: 14152489
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with a lanatoside C preparation soluble in the small intestine].
    HUEDEPOHL M; LEDERBOGEN K
    Med Klin; 1962 May; 57():892-4. PubMed ID: 14449711
    [No Abstract]   [Full Text] [Related]  

  • 20. [Further clinical experiences with lanatoside A].
    KUBAN G
    Med Welt; 1961 Feb; 8():389-92. PubMed ID: 13754745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.